Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Novartis Pharmaceuticals Corporation et al v. West-Ward Pharmaceuticals International-Limited
Case Number:
1:14-cv-01196
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
March 28, 2017
Novartis Gets Partial Win In Transplant-Drug Patent Dispute
Swiss pharmaceutical giant Novartis scored a partial victory Tuesday when a Delaware federal judge said three drugmakers induced infringement of its patents when they filed abbreviated new drug applications for a generic version of Zortress, a medication used to treat organ transplant recipients.
-
September 16, 2014
Novartis Sues Generics Maker Over Organ Rejection Drug
Novartis Pharmaceuticals Corp. hit Roxane Laboratories Inc. with a patent infringement suit in Delaware federal court Tuesday in an effort to block a generic version of Zortress, a medication used to treat organ transplant recipients.